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What's new? 
 This is the first systematic review and meta-analysis to identify interventions 
available for people with Type 1 diabetes mellitus and co-occurring disordered eating, 
and to examine intervention content and efficacy. 
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 Existing interventions do not improve glycaemic control and have little effect on 
eating psychopathology. 
 We suggest that an intensive intervention such as inpatient therapy, with a joint focus 
on disordered eating and diabetes management, is needed. 
 Our data could be used in conjunction with a theoretical model to tailor an 
intervention for this patient group. 
 
Abstract 
Aim To examine the types of interventions currently available for people with Type 1 
diabetes mellitus and their effectiveness. 
Background The prevalence of disordered eating in people with Type 1 diabetes mellitus is 
twice that in their counterparts without diabetes, and is associated with worse biomedical 
outcomes and greater mortality.  
Methods Medline, Embase, PsycINFO, the Cochrane Library, PubMed and OpenGrey 
databases were searched up to August 2016 to identify studies on interventions in people with 
Type 1 diabetes-associated disordered eating. For the systematic review, intervention 
components were identified and their effectiveness was examined. For the meta-analysis, the 
pooled effect sizes of glycaemic control (HbA1c) between pre- and post-treatment in 
treatment and comparison groups were calculated using a random effects model.  
Results Of 91 abstracts reviewed, six studies met the inclusion criteria, of which three had 
appropriate data for the meta-analysis (n = 118). The pooled effect size was –0.21 95% CI (–
0.58 to 0.16; where negative values represent an improvement in HbA1c levels), indicating no 
statistically significant improvement in the treatment group compared with comparison 
group. Inpatient therapy appeared to be the most effective treatment, and this had multiple 
components including cognitive behavioural therapy, psychoeducation and family therapy.  
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Conclusion Limited or no improvement in glycaemic control and disordered eating 
symptoms was observed in people with Type 1 diabetes-associated disordered eating who 
were receiving currently available interventions. The present review suggests that developing 
an intensive intervention with a joint focus on both disordered eating and diabetes 
management is needed for this complex patient group.  
 
Introduction 
The prevalence of eating problems in people with Type 1 diabetes mellitus is twice that in 
their counterparts without diabetes [1–5]. Disordered eating behaviour in Type 1 diabetes is 
most commonly, but not exclusively, associated with bingeing and purging patterns [5,6]. A 
compensatory behaviour specific to Type 1 diabetes involves reducing or omitting insulin 
doses, whereby hyperglycaemia is induced to lose glucose calories through the urine [7]. This 
is the most common weight loss method used by adolescents with Type 1 diabetes [5,8,9], 
being termed 'diabulimia' [6]. Disordered eating has more severe consequences for people 
with diabetes [8]. Type 1 diabetes comorbid with eating disorders is clearly associated with 
higher HbA1c values [10]. In the short term, the consequences of Type 1 diabetes-associated 
disordered eating include more frequent episodes of diabetic ketoacidosis [11] and 
hospitalizations [12], whilst long-term complications involve the onset of diabetic 
microvascular complications at not only a much earlier than expected age [13], but also after 
a shorter duration of disease. Most seriously, the comorbidity carries more than a threefold 
risk of mortality [14,15]. 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The theoretical model proposed by Treasure et al. [16] is the latest attempt to address 
predisposing and maintenance risk factors for disordered eating in Type 1 diabetes. It 
postulates that the salience given to weight and eating in diabetes management interacts with 
a perfectionist coping style, leading to an unhelpful focus on food [17–19] and body weight, 
exacerbating body shape concerns [16]. Further, the goal of perfect glycaemic control can be 
elusive and frustrating [16]. This may explain the lower self- and body-esteem in this group 
[20,21]. The link between insulin treatment and changes in weight offers the possibility of a 
unique way of controlling weight [22]. This leads to wide blood glucose fluctuations (hypo- 
and hyperglycaemia), which may cause neuroadaptive changes that pre-dispose to an 
addictive pattern of loss of control over eating to develop [19,23,24]. Lastly, family frictions 
around the transition to independence can be stressful and can exacerbate psychological 
problems in adolescents with Type 1 diabetes [25]. Family support may be crucial at this time 
[26,27], but it remains unclear what the optimum way to transition from family to 
independent management might be.  
 
We conducted a systematic review to explore the current evidence base with regard to the 
effectiveness of interventions for this complex patient group with Type 1 diabetes and eating 
disorders, and to identify the effective components of treatment. In addition, we conducted a 
meta-analysis to examine the effect of interventions on glycaemic control, namely HbA1c 
concentration.  
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Methods 
Data sources and search strategies 
Medline, Embase, PsycINFO, the Cochrane Library, PubMed and OpenGrey databases were 
searched for all years up to and including August 2016. The search strategy included three 
main terms: 'Type 1 diabetes', 'psychotherapeutic' or 'psychoeducational interventions', and 
'disordered eating'. Synonyms of these were searched to encompass different disciplines and 
all ages. The full electronic search strategy is shown in Table S1.  
 
Study selection 
Articles retrieved from the search were screened by the first author (P.C.) to identify relevant 
titles mentioning eating disorders or Type 1 diabetes. Duplicates were removed using a 
citation manager. Titles and abstracts of potentially eligible articles were independently 
reviewed by P.C. and a second researcher (C.K.), to determine which fulfilled the eligibility 
criteria. Any discrepancies were discussed and agreed upon. Articles where a decision could 
not be made on the basis of reading the title or abstract were read fully. The reference 
sections of retrieved articles were hand-searched for additional references. A third researcher 
(J.T.) was consulted at this stage to finalize studies eligible for the systematic review and 
meta-analysis.  
 
Criteria for inclusion 
Studies were included for the systematic review and meta-analysis if they assessed the 
outcome of treatment interventions for people with comorbid Type 1 diabetes and disordered 
eating. Studies in which components were psychological or educational, not pharmacological, 
were eligible for inclusion. Participants of any age and any sex, with a diagnosis of Type 1 
diabetes, and either disordered eating, insulin omission or a clinical eating disorder were 
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considered.  All types of studies were eligible for systematic review, but only quasi-
experimental or randomized controlled trials (RCTs) with comparison and treatment group 
pre- and post-intervention HbA1c data available were included in the meta-analysis.  
 
Quality assessment 
The quality of reporting of interventions in studies was assessed using the 'template for 
intervention description and replication' (TIDieR). This is a 12-item checklist that was 
primarily developed to encourage authors to describe their interventions in sufficient detail to 
allow replication [28]. The quality of individual studies was examined using the 22 items of 
the STROBE checklist [29]. A study was considered of high quality if the statistical methods, 
variables, data and sources of bias were explicit, and the results were comprehensive such 
that all data were explained and presented.  
 
Data extraction  
From each study we extracted: author names; publication year; city and country; study 
design; sample size; age; sex; treatment components of the intervention; treatment frequency 
and length; times of outcomes and HbA1c. The authors of three studies [30–32] were 
contacted to ask for additional raw data. One author responded but could not provide the data 
required. The TIDieR checklist [28] was used to describe the reporting of the intervention.  
 
Statistical analysis 
For the meta-analysis, we compared HbA1c between treatment and comparison groups where 
mean and SD data were available at the same time point for the two groups. Meta-analyses 
were conducted for two time points because timings of when HbA1c outcomes were measured 
varied between studies. To uniformly compare the studies, we used the following time points: 
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(1) baseline and first follow-up post-intervention and (2) baseline and second follow-up post 
intervention (Table 1 [31,36,37]).  
 
The effect sizes and standard errors of the studies were pooled using random effects models 
[33]. A random effects meta-analysis model assumes that, in addition to the presence of a 
random sampling error, variability of mean effect sizes is also caused by differences in the 
effect between studies attributable to differences in study populations and procedures 
(between-study heterogeneity). The effect size estimate in a random effects model describes 
therefore not one common effect but the average of the effects, and the confidence interval 
describes the degree of heterogeneity [33]. If heterogeneity is present, random effects models 
result in estimates with wider confidence intervals than fixed effects models, but were more 
realistic in the present meta-analysis because of the variety of case mix and settings among 
studies [34]; the random effects model was chosen because of the variety of comparison 
groups used.  
The Cohen’s d approach was used to calculate the effect size. We standardized the mean 
difference in the HbA1c between treatment and comparison groups by calculating the 
difference between the two mean changes (difference of post- and pre-treatment score) 
divided by the pooled SD of the difference scores, assuming a correlation of 0.5 between pre- 
and post-treatment scores. A result of d = 0.3, 0.5 and 0.8 represents small, medium and large 
effect sizes, respectively. Homogeneity of study outcomes was assessed to determine the 
degree of between-study heterogeneity models using the chi-squared test (Q), and the sample 
size independent inconsistency measure I
2
. The small sample size did not allow assessment of 
publication bias.  
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Results 
Study selection  
The literature search produced 891 articles, of which 134 mentioned disordered eating or 
Type 1 diabetes in their title. Duplicates were removed, leaving 91 potentially eligible article 
titles and abstracts to be screened using the inclusion and exclusion criteria. This yielded 17 
for full-text assessment. One additional article was found after manual searching of the 
reference lists. Six articles fulfilled the criteria for the systematic review and three for the 
meta-analysis (Fig. 1). Two of the six articles for systematic review [30,32] were excluded 
from the meta-analysis because they had insufficient comparison group data. The 2002 study 
by Takii et al. [35] was excluded because it was unclear whether it reported data that were 
later included in their 2003 study [31].  
 
Characteristics of studies included 
Six studies were included in the systematic review [30–32,35–37] comprising 205 
participants, all of whom were female. Extracted data are summarized in Table 2 [30–32,35–
37].  One of the studies included was an RCT [36], four were quasi-experimental studies 
[30,31,35,37] and one was a cohort study that did not have a comparison group [32]. All 
studies included in the meta-analysis were either an RCT [36] or had a quasi-experimental 
design [31,37]. Types of comparison groups were ‘treatment as usual’ [36], waiting list [37] 
or an outpatient group (compared with the inpatient group as the treatment group) [31]. Takii 
et al. [31] selected patients for the outpatient (comparison) or inpatient (treatment) group 
according to previously attended therapy, meaning the participants were not of similar 
severity in treatment vs comparison group. Intervention components identified from the 
studies were inpatient therapy [30–32,35], psychoeducation [36,37], 'multidisciplinary' 
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approaches [32], cognitive behavioural therapy [30–32,35], and family involvement 
[31,32,35,36]. 
 
Quality of studies 
Using TIDieR guidelines, all studies did relatively well at describing the rationale of the 
intervention, but not all described the intervention in detail (Table S2). Approaches such as 
‘non-dieting’, ‘non-deprivational’ or ‘feminist’ are not specific and lack examples [32]. Only 
one study reported detailed descriptions of the therapist’s tasks [31]. The interventions 
differed as to whether they had a collaborative approach between the two disciplines in terms 
of the skills of those delivering the intervention and the processes used. There appeared to be 
an emphasis on eating without rules, which is somewhat of a divergent approach to diabetes 
care and this may be because most of them were set within eating disorder settings. Both 
studies by Takii et al. [31,35] had differing follow-up periods for the treatment and 
comparison groups (36 and 24 months, respectively), and did not provide immediate post-
intervention data for the comparison group. Taking all STROBE criteria into consideration, 
two studies were of poor to fair quality [30,35], whilst four were of fair quality [31,32,36,37]. 
The overall risk of bias was medium to high.   
 
Effect of treatment on glycaemic control  
The six studies included in the systematic review report a wide range of HbA1c values at both 
baseline and post-intervention follow-ups. Data vary substantially across studies, with 
baseline mean ± SD values ranging from 65 ± 9 mmol/mol (8.1 ± 0.8%) to 116 ± 32 
mmol/mol (12.8 ± 2.9%) [31,37]. Post-intervention values range from 64 ± 20 mmol/mol (8.0 
± 1.8%), to 119 ± 27 mmol/mol (13 ± 2.5%) [31,35]. Three of the six studies were included 
in the meta-analysis, and the effect sizes calculated show an improvement in glycaemic 
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control in the treatment group in comparison to the control group in all three studies. Studies 
included in the meta-analysis comprised 118 participants [31,36,37]. The effect sizes of 
between groups HbA1c outcomes, comparing treatment to comparison groups, range from –
0.1 (95% CI –1.18 to 0.98) [37] to –1.14 (95% CI –2.13 to –0.15; Table 1) [31], where 
negative values represent an improvement in HbA1c concentration.  
 
Using a random effects model, the meta-analysis (n=118), revealed a small, insignificant 
pooled estimate of the mean standardized effect sizes at both first [d=–0.21 (–0.58 to 0.16); 
P=0.266 (Fig. 2a)] and second time point [d=–0.40 (–0.99 to 0.20); P=0.194 (Fig. 2b)]. Little 
(Q=0.99, I
2
=0%) and moderate (Q=0.1, I
2
=43%) between-group heterogeneity was observed 
for the meta-analyses respectively. 
 
Effect of treatment on eating disorder symptom outcomes 
Significant improvement in eating disorder symptoms in the treatment group compared with 
the control group post-intervention, as measured by the Eating Disorder Inventory (EDI) 
[38], were found across four studies. A reduction in EDI symptom score signifies 
improvement. One study used multivariate analyses to look at the effect of time on eating 
disorder attitudes [36]. They reported a statistically significant time effect for the treatment 
group, but not for the comparison group in two of the three subscales of EDI [36], indicating 
an improvement in attitudes that occurred only in the treatment group over time. Another 
study analysed the time effect, as well as interaction effect between the treatment and 
comparison groups, but found no statistically significant time effect or interaction effect 
between groups, which meant there was no improvement in eating disorder attitudes over 
time, irrespective of group [37]. Another study reported a statistically significant reduction in 
global EDI scores in the treatment group compared with the control group [31]. A fourth 
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study reported statistically significant reductions on each of the five EDI scales [32]. The 
final study reported a statistically significant reduction in EDI scores at 36 months' follow-up 
compared with baseline [35]. 
 
Insulin omission 
Some studies used insulin omission as an outcome measure. One study reported a statistically 
significant change in the percentage of participants in the inpatient treatment group, 
compared with the comparison group, who omitted insulin at first visit compared with 
follow-up [31]. Another study reported a reduction in the number of days insulin was omitted 
over 28 days in the intervention group compared with the 'treatment as usual' group, but the 
reduction was not statistically significant [36]. The third study found no statistically 
significant change in insulin omission between the treatment and waiting list control groups 
at the post-intervention time point compared with baseline [37]. 
 
With no common eating disorder symptom measurement instrument across all studies, a 
meta-analysis could not be performed on this outcome. 
 
Discussion 
The aim of the present review was to identify the components of interventions for those with 
comorbid Type 1 diabetes and disordered eating, and to examine their effectiveness, in terms 
of improved glycaemic management and eating disorder symptoms. Six studies were 
included in this review and our results suggest that there were insignificant improvements in 
glycaemic control post-intervention in the treatment groups compared with controls, while 
some improvement in eating disorder symptoms and reduction in insulin omission was 
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reported in the treatment groups in a few studies [31,32,36]. One study [30] showed no 
improvements across any of the variables. 
 
The present findings should, however, be interpreted in the context of the quality of studies 
involved. Some studies carried a higher risk of bias than others, which could influence the 
interpretation of the results of the present review. Most of the six studies were of fair quality, 
and some were medium level or had unknown risks of bias, using the STROBE criteria. The 
RCT [36] had the lowest level risk of bias. 
 
The intensity and complexity of treatment is considered to have an impact on efficacy; 
inpatient therapy appears to be more effective than outpatient therapy. The average length of 
stay for inpatient therapy reflects the potential intensity of this treatment. Compared with 
outpatient therapy, where an intervention took place weekly for 6 weeks, components of 
inpatient therapy occurred daily for 3–4 months. Inpatient therapy was associated with a 
moderate change in HbA1c outcomes [31,32], whereas only small effects were found with 
outpatient psychoeducational interventions. The psychoeducation studies [36,37] also showed 
a lesser difference in eating disorder symptom reduction compared with the inpatient therapy 
studies [31,32]. The duration of treatment could therefore have an influence on the intensity 
and hence effectiveness of treatment. Other reviews have also noted that 'more intensive 
treatment approaches' than those for uncomplicated eating disorders may be needed to treat 
eating disorder-associated Type 1 diabetes [39,40].  
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Inpatient treatment is a complex intervention with multiple components such as 
psychoeducation, cognitive behavioural therapy, and family work. It also involves frequent 
nurse supervision, which could potentially overcome barriers of patient disengagement, 
patients’ reporting of incorrect HbA1c values, or dishonesty about insulin administration, that 
have been observed in outpatient eating disorder treatment [41].  
 
Interventions with family support/involvement components may have a role in reducing 
eating disorder symptoms as well. Olmsted et al. [36] added a ‘family component’ to their 6-
week psychoeducation programme, whilst Alloway et al. [37] gave psychoeducation without 
additional family involvement components. The former programme resulted in a larger 
change in symptoms [36] than the latter [37]. This has the potential to validate the role of 
family functioning in the maintenance model described by Treasure et al. [16]. 
 
Together, this suggests the need for a joint or tailored ‘diabetes-associated eating disorder’ 
intervention, whereby the specific needs of each illness are addressed, as well as a focus 
being given to unique features of the two illnesses being concurrent, such as insulin 
administration linked to carbohydrate balance. This may mean that the goals and processes of 
the diabetes and eating disorder teams may need to be fused. For example the diabetes team 
may need to join up with a slow stepwise programme of increasing insulin administration 
during which the individual is taught skills for managing the negative emotions elicited by 
the meaning of diabetes and insulin for them. Meanwhile, the eating disorder team may need 
to join up with the form of rule-bound eating and adjustments to exercise which are needed as 
part of good diabetes care.  
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Whilst these data support what has been argued in the literature for years, evidence 
previously has been anecdotal, or based only on clinical experience or small sample sizes 
[41]. This review has strengths in its systematic reporting and analysis of collated data 
allowing a larger sample size, and its presentation of findings in the larger context of the 
disordered eating and comorbid Type 1 diabetes complication. 
The major limitation of the present review was the small number of studies available. For the 
most part, the components of the interventions are also poorly described, and only one RCT 
was performed. In addition, the quality of individual studies was poor to fair, introducing a 
medium to high risk of bias. Two studies did not have comparison group data [30,32]. A 
further two studies did not have raw data available and used differing time points for post-
intervention follow-up across their treatment and comparison groups [31,35]. One study 
followed up individuals for 1 month after a 6-week intervention, limiting the value of HbA1c 
(a 3-month average glycaemic level) as an outcome measure [37]. Another limitation is that 
the included studies did not always specify the type of eating disorder. This is important as 
the goals for treatment differ between anorexia nervosa and bulimia nervosa. With more data, 
a future point of research could be to examine interaction effects of eating disorder type or 
severity.  Additionally, the individuals’ attendance to therapy throughout the study was not 
addressed; however, whilst attrition rate can be reported, measuring active engagement in 
therapy is difficult. This introduces a limitation that could have influenced the effectiveness 
reported in the studies. 
 
The included studies also used differing comparison groups; one used a waiting list control 
[37], others used ‘treatment as usual’ [30,31,35,36]. This also raises concerns with regard to 
the degree to which ‘treatment as usual’ is standardized across studies [42]. Finally, the use 
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of different instruments to measure eating disorder symptoms meant a meta-analysis could 
not be performed on this outcome. 
 
Lastly, it should be noted that TIDieR criteria revealed intervention reporting quality to be 
thorough in only one study [31]. Good reporting increases the validity of findings and the 
conviction with which the efficacy of interventions can be reported. Not only does this imply 
that this study [31] may be of more use for future intervention development than others, but it 
also emphasizes wherein the weaknesses lie in the existing studies in this area of research. 
We therefore suggest that targeting intervention reporting and describing in the future could 
provide more insight into the specifics of a successful intervention.  
 
In conclusion, people with Type 1 diabetes-associated eating disorders have a poorer 
response of their eating disorder symptoms to conventional eating disorder management, and 
little improvement in their diabetic control. It appears that people with Type 1 diabetes-
associated eating disorders require a different form and intensity of intervention. The 
development of interventions for this group might follow the principles of the Medical 
Research Council guidelines for developing complex interventions [43]. The first step in this 
type of approach has been undertaken by the development of a theoretical model [16]. This 
could be used to tailor conventional eating disorders and diabetes interventions, especially to 
include concurrent diabetes and eating disorder components.  
 
Funding sources 
C.K. currently receives salary support from the Novo Nordisk UK Research Foundation, 
National Institute for Health Research (NIHR) Biomedical Research Centre for Mental 
Health at South London and from the Maudsley National Health Service (NHS) Foundation 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Trust in the past. K.I. and J.T. receive funding from the NIHR Mental Health Biomedical 
Research Centre at South London and Maudsley NHS Foundation Trust and King's College 
London. 
 
Competing interests 
None declared.  
 
Acknowledgements 
We would like to thank statistician Sam Norton.  
 
References 
1. Wisting L, Froisland DH, Skrivarhaug T, Dahl-Jorgensen K, Ro O. Disturbed eating 
behavior and omission of insulin in adolescents receiving intensified insulin treatment: a 
nationwide population-based study. Diabetes Care 2013;36:3382–3387. 
2. Raevuori A, Haukka J, Vaarala O, Suvisaari JM, Gissler M, Grainger M et al. The 
Increased Risk for Autoimmune Diseases in Patients with Eating Disorders. PLoS One 
2014;9:e104845. 
3. de Jonge P, Alonso J, Stein DJ, Kiejna A, Aguilar-Gaxiola S, Viana MC et al. Associations 
between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders 
and depression. Diabetologia 2014;57:699–709. 
4. Young V, Eiser C, Johnson B, Brierley S, Epton T, Elliott J et al. Eating problems in 
adolescents with Type 1 diabetes: a systematic review with meta-analysis. Diabet Med 
2013;30:189–198. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
5. Jones JM, Lawson ML, Daneman D, Olmsted MP, Rodin G. Eating disorders in adolescent 
females with and without type 1 diabetes: cross sectional study. BMJ 2000;320:1563–1566. 
6. Shaban C. Diabulimia: mental health condition or media hyperbole? Practical Diabetes 
2013;30:104–105a. 
7. Prasad-Reddy L. Disordered eating in type 1 diabetes: Insulin omission and diabulimia. US 
Pharm 2012; 37(5). 
8. Larranaga A, Docet M, Garcia-Mayor RV. Disordered eating behaviors in type 1 diabetic 
patients. World J Diabetes 2011;2:189–195. 
9. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin 
omission in women with IDDM. Diabetes Care 1994;17:1178–1185. 
10. Figueroa Sobrero A, Evangelista P, Mazza C, Basso P, Lopez SM, Scaiola E et al. Three-
year follow up of metabolic control in adolescents with type 1 diabetes with and without 
eating disorders. Arch Argent Pediatr 2010; 108:130–135. 
11. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin 
omission in women with IDDM. Diabetes Care 1994;17:1178–1185. 
12. Cohn BA, Cirillo PM, Wingard DL, Austin DF, Roffers SD. Gender Differences in 
Hospitalizations for IDDM Among Adolescents in California, 1991: Implications for 
prevention. Diabetes Care 1997; 20:1677–1682. 
13. Steel JM, Young RJ, Lloyd GG, Clarke BF. Clinically apparent eating disorders in young 
diabetic women: associations with painful neuropathy and other complications. Br Med J  
1987;294:859–862. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
14. Nielsen S, Emborg C, Mølbak A. Mortality in Concurrent Type 1 Diabetes and Anorexia 
Nervosa. Diabetes Care 2002; 25:309–312. 
15. Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K. Insulin 
Restriction and Associated Morbidity and Mortality in Women with Type 1 Diabetes. 
Diabetes Care 2008;31:415–419. 
16. Treasure J, Kan C, Stephenson L, Warren E, Smith E, Heller S et al. Developing a 
theoretical maintenance model for disordered eating in Type 1 diabetes. Diabetic Med 
2015;32:1541–1545. 
17. Young-Hyman DL, Davis CL. Disordered Eating Behavior in Individuals With Diabetes: 
Importance of context, evaluation, and classification. Diabetes Care 2010;33:683–689. 
18. Polivy J, Herman CP. Dieting and binging. A causal analysis. Am Psychol 1985;40:193–
201. 
19. Goebel-Fabbri AE, Fikkan J, Connell A, Vangsness L, Anderson BJ. Identification and 
treatment of eating disorders in women with type 1 diabetes mellitus. Treat Endocrinol 2002; 
1:155–162. 
20. Wolman C, Resnick MD, Harris LJ, Blum RW. Emotional well-being among adolescents 
with and without chronic conditions. J Adolescent Health 1994;15:199-204. 
21. Grylli V, Wagner G, Berger G, Sinnreich U, Schober E, Karwautz A. Characteristics of 
self-regulation in adolescent girls with Type 1 diabetes with and without eating disorders: A 
cross-sectional study. Psychol Psychother 2010;83:289–301. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
22. Larger E. Weight gain and insulin treatment. Diabetes Metab 2005; 31(4, Part 2):4S51–
4S56. 
23. Rodin GM, Daneman D. Eating Disorders and IDDM: A problematic association. 
Diabetes Care 1992;15:1402–1412. 
24. Alsiö J, Olszewski PK, Levine AS, Schiöth HB. Feed-forward mechanisms: Addiction-
like behavioral and molecular adaptations in overeating. Front Neuroendocrinol 
2012;33:127–139. 
25. Maharaj SI, Rodin GM, Olmsted MP, Daneman D. Eating disturbances, diabetes and the 
family: an empirical study. J Psychosom Res 1998; 44:479–490. 
26. Hanson CL, Cigrang JA, Harris MA, Carle DL, Relyea G, Burghen GA. Coping styles in 
youths with insulin-dependent diabetes mellitus. J Consult Clin Psychol 1989;57:644–651. 
27. Schwartz SA, Weissberg-Benchell J, Perlmuter LC. Personal Control and Disordered 
Eating in Female Adolescents With Type 1 Diabetes. Diabetes Care 2002;25:1987. 
28. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D et al. Better 
reporting of interventions: template for intervention description and replication (TIDieR) 
checklist and guide. BMJ 2014 BMJ Publishing Group Ltd ;348. 
29. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al. 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: 
guidelines for reporting observational studies. BMJ 2007; 335: 806–808. 
30. Custal N, Arcelus J, Aguera Z, Bove F, Wales J, Granero R et al. Treatment outcome of 
patients with comorbid type 1 diabetes and eating disorders. BMC Psychiatry 2014;14:140. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
31. Takii M, Uchigata Y, Komaki G, Nozaki T, Kawai H, Iwamoto Y et al. An integrated 
inpatient therapy for type 1 diabetic females with bulimia nervosa: a 3-year follow-up study. 
J Psychosom Res 2003;55:349–356. 
32. Dickens YL, Haynos AF, Nunnemaker S, Platka-Bird L, Dolores J. Multidisciplinary 
Residential Treatment of Type 1 Diabetes Mellitus and Co-Occurring Eating Disorders. Eat 
Disord 2014:1–10. 
33. Borenstein M, Hedges L, Higgins J, Rothstein, H. Introduction to Meta-Analysis. Wiley; 
2009. 
34. Everitt B. Modern Medical Statistics: A Practical Guide. London; 2002. 
35. Takii M, Uchigata Y, Komaki G, Nozaki T, Kawai H, Iwamoto Y. A 
cognitive/behavioural appraoch to type 1 diabetic females with recurrent binge eating : A 3-
year follow-up study. Int Congress Series 2002;1241:291–296. 
36. Olmsted MP, Daneman D, Rydall AC, Lawson ML, Rodin G. The effects of 
psychoeducation on disturbed eating attitudes and behavior in young women with type 1 
diabetes mellitus. Int J Eat Disord 2002; 32: 230–239. 
37. Alloway SC, Toth EL, McCargar LJ. Effectiveness of a group psychoeducation program 
for the treatment of subclinical disordered eating in women with type 1 diabetes. Can J Diet 
Pract Res 2001;62:188–192. 
38. Garner DM, Olmstead MP, Polivy J. Development and validation of a multidimensional 
eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 1983; 2:15–34. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
39. Rodin G, Olmsted MP, Rydall AC, Maharaj SI, Colton PA, Jones JM et al. Eating 
disorders in young women with type 1 diabetes mellitus. J Psychosom Res 2002; 53: 943–
949. 
40. Pinhas-Hamiel O, Hamiel U, Levy-Shraga Y. Eating disorders in adolescents with type 1 
diabetes: Challenges in diagnosis and treatment. World J Diabetes 2015; 6:517–526. 
41. Peveler RC, Fairburn CG. The treatment of bulimia nervosa in patients with diabetes 
mellitus. Int J Eat Disord 1992;11:45–53. 
42. Ayling K, Brierley S, Johnson B, Heller S, Eiser C. How standard is standard care? 
Exploring control group outcomes in behaviour change interventions for young people with 
type 1 diabetes. Psychol Health 2014;30:85–103. 
43. Eiser C, Johnson B, Brierley S, Ayling K, Young V, Bottrell K et al. Using the Medical 
Research Council framework to develop a complex intervention to improve delivery of care 
for young people with type 1 diabetes. Diabet Med 2013; 30:e223–228. 
44. Garner DM, Garfinkel PE. The Eating Attitudes Test: an index of the symptoms of 
anorexia nervosa. Psychol Med 1979;9:273–279. 
45. Cooper Z, Fairburn C. The eating disorder examination: A semi-structured interview for 
the assessment of the specific psychopathology of eating disorders. Int J Eat Disord 
1987;6:1–8. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Supporting information 
Additional Supporting Information may be found in the online version of this article:  
 
Table S1 Search Terms from a full OVID electronic search. 
Table S2 Assessing reporting quality of interventions: the TIDieR checklist for each study 
eligible for systematic review. 
 
FIGURE 1 PRISMA flow chart of information collection for systematic review and meta-
analysis. 
FIGURE 2 (a) Forest plot presenting the treatment effect results of meta-analysis: treatment 
effect sizes for HbA1c of first follow-up post-intervention. (b) Forest plot presenting the 
treatment effect results of meta-analysis: treatment effect sizes for HbA1c of second follow-up 
post-intervention. ES, effect size. 
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Table 1 HbA1c outcome data and effect sizes (calculated between pre-treatment and follow-ups) for each study included in the meta-analysis 
  Mean ± SD HbA1c concentration, mmol/mol (%) 
  
Pre-treatment, 
 
Post-intervention  1-month follow-up 6-month follow-up 12-month follow-up 
Alloway et al., 2001 
[37] 
Comparison group 
65 ± 9 
(8.1 ± 0.8) 
67 ± 10 
(8.3 ± 0.9) 
67 ± 7 
(8.3 ± 0.6) 
N/A N/A 
Treatment group 
66 ± 13 
(8.2 ± 1.2) 
67 ± 12 
(8.3 ± 1.1) 
66 ± 13 
(8.2 ± 1.2) 
N/A N/A 
Effect size (SE)  –0.10 (0.540) –0.19 (0.541) N/A N/A 
Olmsted et al., 2002 
[36] 
Comparison group 
75 ± 13 
(9.0 ± 1.2) 
76 ± 17 
(9.1 ± 1.6) 
N/A 
78 ± 16 
(9.3 ± 1.5) 
N/A 
Treatment group 
77 ± 17 
(9.2 ± 1.6) 
76 ± 17 
(9.1 ± 1.6) 
N/A 
78 ± 19 
(9.3 ± 1.7) 
N/A 
Effect size (SE)   –0.13 (0.221) N/A –0.13 (0.221) N/A 
Takii et al., 2003 [31] 
Comparison group 
116 ± 32 
(12.8 ± 2.9) 
N/A N/A 
112 ± 24 
(12.4 ± 2.2
†
) 
119 ± 27 
(13.0 ± 2.5
†
) 
Treatment group 
110  ± 19 
(12.2 ± 1.7) 
N/A N/A 
89 ± 23 
(10.3* ± 2.1
†
) 
81 ± 26 
(9.6* ± 2.4
†
) 
Effect size (SE)  N/A N/A –0.65 (0.471) –1.14 (0.495) 
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N/A, data not supplied in study. 
Effect size is calculated for each follow-up time point, using the pre-treatment baseline data. 
*Significant (P<0.05). 
†
SD was calculated using SE value given in paper. 
 
 
 
Table 2  Characteristics of studies included in the systematic review 
 
Alloway et al. 2001 
[37] 
Olmsted et al., 
2002 [36] 
Takii et al., 
2003 [31] 
Takii et al., 
2002 [35] 
Dickens et al., 
2014 [32] 
Custal et al., 2014 [30] 
Study design Quasi-experimental RCT  
Quasi-
experimental 
Quasi-
experimental 
Cohort study Quasi-experimental  
Sample 
size 
Comparison 6 35 10 9 N/A 20 
Treatment 8 50 9 9 29 20 
Total 14 85 19 18 29 40 
Women (%) 100 100 100 100 100 100 
Age ± SD 
Comparison 
Treatment 
31.0 ± 10.3 
16 ± 2.0 
21.3 ± 4.0 
N/S 25.6 ± 9.0 
28.0 ± 8.4 
32.5 ± 9.3 23.8 ± 5.0 25.3 ± 8.0 
City, Country Edmonton, Canada Toronto, Canada Kyushu, Japan Kyushu, Japan Western USA Barcelona, Spain 
Treatment setting OUT OUT IN IN OUT OUT-CBT 
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and 
IN 
and 
IN 
Intervention 
components 
reported in each 
study 
IN       
Psychoeducation       
MULTI       
CBT       
FAM       
Treatment frequency Weekly Weekly Daily Daily Daily 
CBT: N/S 
IN: Daily 
Mean length of treatment  6 weeks  6 weeks  112.3 days 112.3 days 52.9 days 
CBT: 16 sessions 
IN: 3 months 
Follow-up period 1 month  6 months 3 years 3 years Post-intervention Post-intervention 
Outcome measures  
HbA1c; self-care 
inventory; EAT; 
EDI-3; insulin 
omission frequency 
HbA1c; objective 
binge-eating 
episodes; EDI; 
EDE; insulin 
omission frequency 
HbA1c; EDI; 
insulin 
omission 
frequency 
 
HbA1c; EDI; 
insulin omission 
frequency 
 
HbA1c; EDI-3; 
 
Frequency of binges/ 
vomiting/laxatives/diuret
ics; 
EDI-2 
CBT, cognitive/behavioural therapy; EAT, Eating Attitudes Test [44]; EDE, Eating Disorder Examinations [45]; EDI, Eating Disorder Inventory [38]; FAM, family involvement; IN, inpatient 
therapy; MULTI, multidisciplinary approach; N/S, not specified; N/A, not applicable (data not collected); OUT, outpatient therapy.  
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